429 related articles for article (PubMed ID: 19203058)
1. [Nephrogenic systemic fibrosis--new clinical entity].
Prvulović M
Med Pregl; 2008; 61(9-10):439-41. PubMed ID: 19203058
[TBL] [Abstract][Full Text] [Related]
2. [Nephrogenic systemic fibrosis].
Breitschaft A; Stahlmann R
Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
[TBL] [Abstract][Full Text] [Related]
3. Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.
Pietsch H; Lengsfeld P; Steger-Hartmann T; Löwe A; Frenzel T; Hütter J; Sieber MA
Invest Radiol; 2009 Apr; 44(4):226-33. PubMed ID: 19252439
[TBL] [Abstract][Full Text] [Related]
4. [Nephrogenic systemic fibrosis and use of MR contrast media].
Christiansen RE; Sviland L; Sekse I; Svarstad E
Tidsskr Nor Laegeforen; 2009 Jan; 129(3):180-2. PubMed ID: 19180161
[TBL] [Abstract][Full Text] [Related]
5. Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
Grant D; Johnsen H; Juelsrud A; Løvhaug D
Acta Radiol; 2009 Mar; 50(2):156-69. PubMed ID: 19160079
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenic systemic fibrosis: clinical picture and treatment.
Marckmann P; Skov L
Radiol Clin North Am; 2009 Sep; 47(5):833-40, vi. PubMed ID: 19744598
[TBL] [Abstract][Full Text] [Related]
7. Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure.
Grobner T; Prischl FC
Semin Dial; 2008; 21(2):135-9. PubMed ID: 18226001
[TBL] [Abstract][Full Text] [Related]
8. Nephrogenic systemic fibrosis: more questions and some answers.
Morcos SK; Thomsen HS
Nephron Clin Pract; 2008; 110(1):c24-31; discussion c32. PubMed ID: 18688172
[TBL] [Abstract][Full Text] [Related]
9. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
Broome DR
Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
Peak AS; Sheller A
Ann Pharmacother; 2007 Sep; 41(9):1481-5. PubMed ID: 17684032
[TBL] [Abstract][Full Text] [Related]
11. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
Sieber MA; Pietsch H; Walter J; Haider W; Frenzel T; Weinmann HJ
Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation.
Wilford C; Fine JD; Boyd AS; Sanyal S; Abraham JL; Kantrow SM
Am J Dermatopathol; 2010 Feb; 32(1):71-5. PubMed ID: 19940755
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic systemic fibrosis: a review of the new conundrum.
Goenka AH; Das CJ; Sharma R
Natl Med J India; 2009; 22(6):302-6. PubMed ID: 20384019
[TBL] [Abstract][Full Text] [Related]
14. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
Kay J
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of NSF: New evidence challenging the prevailing theory.
Newton BB; Jimenez SA
J Magn Reson Imaging; 2009 Dec; 30(6):1277-83. PubMed ID: 19937925
[TBL] [Abstract][Full Text] [Related]
16. Nephrogenic systemic fibrosis and its impact on abdominal imaging.
Prince MR; Zhang HL; Prowda JC; Grossman ME; Silvers DN
Radiographics; 2009 Oct; 29(6):1565-74. PubMed ID: 19959508
[TBL] [Abstract][Full Text] [Related]
17. Nephrogenic systemic fibrosis: histology and gadolinium detection.
Thakral C; Abraham JL
Radiol Clin North Am; 2009 Sep; 47(5):841-53, vi-vii. PubMed ID: 19744599
[TBL] [Abstract][Full Text] [Related]
18. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.
Wiedemeyer K; Kutzner H; Abraham JL; Thakral C; Carlson JA; Tran TA; Hausser I; Hartschuh W
Am J Dermatopathol; 2009 Oct; 31(7):674-81. PubMed ID: 19633532
[TBL] [Abstract][Full Text] [Related]
19. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review.
Sanyal S; Marckmann P; Scherer S; Abraham JL
Nephrol Dial Transplant; 2011 Nov; 26(11):3616-26. PubMed ID: 21441397
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
Thakral C; Abraham JL
J Cutan Pathol; 2009 Dec; 36(12):1244-54. PubMed ID: 19602073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
